Yuichi Kumagae
Overview
Explore the profile of Yuichi Kumagae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujisaki Y, Fukukura Y, Kumagae Y, Ejima F, Yamagishi R, Nakamura S, et al.
Pancreas
. 2023 Apr;
51(10):1352-1358.
PMID: 37099778
Objective: The aim of the study is to evaluate the usefulness of virtual monoenergetic imaging (VMI) generated from dual-energy computed tomography (DECT) in detecting small pancreatic ductal adenocarcinomas (PDACs). Methods:...
2.
Nagata A, Shinden Y, Nomoto Y, Saho H, Nakajo A, Minami K, et al.
Surg Case Rep
. 2022 Jan;
8(1):13.
PMID: 35038044
Background: It is quite rare for breast cancer to metastasize to the kidney with a tumor thrombus in the inferior vena cava. Case Presentation: A Japanese woman in her forties...
3.
Fukukura Y, Kumagae Y, Fujisaki Y, Nakamura S, Nickel M, Imai H, et al.
Eur J Radiol
. 2021 Nov;
145:110036.
PMID: 34814039
Purpose: To assess the feasibility of extracellular volume (ECV) fraction determined with equilibrium contrast-enhanced MRI for prediction of treatment response to chemotherapy in pancreatic ductal adenocarcinoma (PDAC) in comparison with...
4.
Nagano H, Takumi K, Nakajo M, Fukukura Y, Kumagae Y, Jinguji M, et al.
AJR Am J Roentgenol
. 2021 Jul;
218(1):66-74.
PMID: 34319164
. Accurate nodal staging is essential to guide treatment selection in patients with non-small cell lung cancer (NSCLC). To our knowledge, measurement of electron density (ED) using dual-energy CT (DECT)...
5.
Fukukura Y, Kumagae Y, Fujisaki Y, Yamagishi R, Nakamura S, Kamizono J, et al.
AJR Am J Roentgenol
. 2021 Mar;
217(4):888-897.
PMID: 33759561
Contrast-enhanced CT performed for pancreatic ductal adeno-carcinoma (PDAC) detection traditionally uses a dual-phase (pancreatic and portal venous) protocol. However, PDAC may exhibit isoattenuation in these phases, hindering detection. The purpose...
6.
Takumi K, Nagano H, Kikuno H, Kumagae Y, Fukukura Y, Yoshiura T
Sci Rep
. 2021 Feb;
11(1):2780.
PMID: 33531644
The purpose of this study is to determine whether multiparametric non-contrast MR imaging including diffusion-weighted imaging (DWI), arterial spin labeling (ASL), and amide proton transfer (APT) weighted imaging can help...
7.
Takumi K, Hakamada H, Nagano H, Fukukura Y, Kumagae Y, Sakai O, et al.
Jpn J Radiol
. 2020 Nov;
39(4):324-332.
PMID: 33215300
Purpose: To evaluate the usefulness of dual-energy analyses using dual-layer spectral CT (DLSCT) for diagnosing recurrent lesions of head and neck squamous cell carcinoma (HNSCC). Materials And Methods: The study...
8.
Fukukura Y, Kumagae Y, Higashi R, Hakamada H, Nagano H, Hidaka S, et al.
Pancreatology
. 2020 Aug;
20(6):1155-1163.
PMID: 32800574
Background: Pancreatic ductal adenocarcinoma (PDAC) has substantial heterogeneity in biophysical features and in outcomes of patients. Identifying reliable pretreatment imaging biomarkers for PDAC with distant metastases (stage IV) is a...
9.
Takumi K, Nagano H, Nakanosono R, Kumagae Y, Fukukura Y, Yoshiura T
Neuroradiology
. 2020 Jun;
62(10):1293-1299.
PMID: 32577772
Purpose: To determine whether combined signal averaging and compressed sensing (CS averaging) improves the image quality of contrast-enhanced fat-suppressed T1-weighted three-dimensional turbo field-echo (FS T1W 3D-TFE) for evaluation of pharyngolaryngeal...
10.
Fukukura Y, Kumagae Y, Higashi R, Hakamada H, Nakajo M, Maemura K, et al.
Eur Radiol
. 2019 Nov;
30(3):1679-1689.
PMID: 31728691
Objectives: To evaluate the feasibility of equilibrium contrast-enhanced dual-energy CT (DECT), as compared with single-energy CT (SECT) and to calculate extracellular volume (ECV) fraction to predict the survival outcomes of...